维普中文期刊产品整合服务
8篇 您的检索式:作者名="GASTOLDI S"
    题名 作者 年代 出处 被引量
1Rituximab as pre-emptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti-ADAMTS13autoantibodies显示文摘Bresin E Gastoldi S Daina E 2009Thromb Haemost2009,101,2:1
2Rituximab as preemptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti ADAMTS13 autoantibodies显示文摘Bresin E Gastoldi S Daina E 2009Thromb Haemost2009,101,2:1
3Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis 显示文摘Morigi M Galbusera M Gastoldi S 2011J Immunol2011,187,1:1
4Rituximab as pre- emptive treatment in patients with thrombotic thrombocytope- nic purpura and evidence of anti ADAMTS13 autoantibodies 显示文摘Bresin E Gastoldi S Daina E 2009Thromb Haemost2009,101,2:1
5Ritux-imab as pre-emptive treatment in patients with throm-botic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodies 显示文摘BRESIN E GASTOLDI S DAINA E 2009Thromb Haemost2009,101,:1
6Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis 显示文摘Morigi M Galbusera M Gastoldi S 2011J Immunol2011,187,1:1
7Rituximab as pre-emptivetreatment in patients with thrombotic thrombocytopenic pur-pura and evidence of anti ADAMTS13 autoantibodies 显示文摘Bresin E’Gastoldi S Daina E 2009Thromb Haetnost2009,101,2:1
8Rituximab as preemptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti-ADAMTS13autoantibodies显示文摘Bresin E Gastoldi S Daina E 2009Thromb Haemost2009,101,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费